About Filoviruses

Overview

Filovirus infection refers to the infection caused by a group of viruses known as filoviruses. Filoviruses are a type of virus with genetic material called negative-sense RNA. This means their RNA needs to be converted into a usable form by the infected cell before the virus can grow and reproduce. These viruses can cause severe illnesses, including death, in humans and non-human primates. The two main genera of filoviruses that are known to cause disease in humans are Ebolavirus and Marburgvirus.

Filovirus infections are typically transmitted through contact with infected individuals or animals, such as African fruit bats or infected non-human primates. Human-to-human transmission can also occur through direct contact with infected bodily fluids or contaminated materials.

The symptoms of filovirus infection can include high fever, fatigue, muscle and joint pain, sore throat, nausea, vomiting, abdominal pain, and diarrhea. The incubation period for filovirus infections can range from 2 to 21 days.

Filovirus infections have high case fatality rates, reaching up to 90% depending on the virus strain and clinical care provided. Development and testing of vaccines and medical countermeasures for filoviruses is challenging due to the sporadic nature of outbreaks.

Causes and Risk Factors

The disease causes of filovirus infection are not clearly understood, but it is believed that the virus is transmitted through direct or indirect contact with infected blood, organs, or body fluids from infected humans or animals. Bats are thought to be the reservoir for filoviruses. The virus can cause severe disease in humans and non-human primates, leading to high fatality rates.

Risk factors for filovirus include:

• Occupation: People involved in artisan gold mining have a higher likelihood of exposure to filoviruses, possibly due to increased contact with bats.
• Gender: Males have been found to have a higher chance of testing positive for filovirus antibodies, which shows they were exposed to the virus in the past.
• Contact with suspect filovirus cases: People who have had contact with individuals suspected of having a filovirus infection are at an increased risk.

Practicing good hygiene, avoiding contact with infected individuals or animals, and following appropriate infection control measures can help reduce the risk of acquiring filovirus infection.

Please consult a healthcare professional for personalized advice regarding the prevention and management of filovirus infection.

Symptoms

The most common early symptoms of filovirus infection include:

• Fever
• Headache
• Body aches
• Fatigue

As the infection progresses or reaches a higher severity, the following symptoms may occur:

• Gastrointestinal issues: Stomach problems like nausea, vomiting, diarrhea, or pain
• Declining health: Getting weaker or sicker over time
• High levels of proinflammatory cytokines and chemokines: Proteins in the body that cause harmful inflammation
• Vomiting
• Diarrhea
• Hemorrhage: Severe bleeding inside or outside the body
• Shock: A life-threatening condition where organs don’t get enough blood or oxygen
• End organ failure: When major organs, like the liver or kidneys, stop working

It's important to note that variations in clinical presentations between individuals can complicate case identification. Additionally, fever may not be reported or observed in some cases, and the presence of hemorrhagic symptoms can vary widely. If you experience any of these symptoms or suspect a filovirus Infection, it is crucial to seek medical attention immediately.

Diagnosis

To diagnose filovirus infection, the following examinations, tests, and procedures are commonly performed:

• Direct identification of viral particles, proteins, or specific RNA in blood samples can be done using tests such as electron microscopy (uses a powerful microscope to see the virus), histological techniques (examines tissue samples for signs of the virus), and immunofluorescence (uses glowing antibodies to detect the virus).
• Nucleic acid amplification tests (NAAT) to find the virus’s genetic material, called RNA. These tests include RT-PCR (reverse transcriptase polymerase chain reaction) and qRT-PCR (quantitative reverse polymerase chain reaction). They work by making many copies of the virus’s RNA so even tiny amounts can be detected, which helps confirm the infection.
• Rapid tests can quickly detect Ebola virus in deceased individuals, helping confirm if they were infected.

To determine the severity of filovirus infection, additional examinations, tests, and procedures may include:

• Plasma viremia levels: Measuring the amount of virus in the blood (viremia) using nucleic acid tests (NATs), such as RT-PCR. Higher viremia levels can indicate a more severe infection and greater risk of complications.
• Imaging studies: X-rays or MRIs (magnetic resonance imaging) scans may be used to detect organ damage, brain swelling, or other physical complications caused by the virus.
• Organ function tests: Blood tests to evaluate liver, kidney, and other organ functions can help assess how severely the virus has affected the body.

It's important to note that these diagnostic methods should be performed in specialized laboratories due to the high biohazard risk associated with filovirus infection. Always consult with your healthcare provider for accurate diagnosis and appropriate management.

Treatment Options

The goals of treatment for filovirus Infection are to:

• Provide supportive care: Supportive care focuses on managing symptoms and complications to improve the patient's overall well-being. It includes measures such as maintaining hydration, managing fever, providing pain relief, and addressing any other symptoms that may arise.
• Early diagnosis: Early diagnosis is crucial in order to initiate appropriate treatment promptly. Diagnostic tests, such as nucleic acid testing, can detect the presence of the virus in the early stages of infection before the immune response develops.
• Post-exposure prophylaxis (PEP) for Zaire ebolavirus only: PEP involves administering vaccines or antibodies to individuals who have been exposed to the virus but have not yet developed symptoms. Studies have shown that PEP can increase survival rates even when administered a few days after exposure.
• Monoclonal antibodies (mAbs) therapy: Monoclonal antibodies are specific antibodies designed to target and neutralize the virus. They can be used as a treatment option for individuals with filovirus infection, providing rapid immunity and potentially reducing the severity of the disease.
• Combination therapy: Researchers are studying how combining different approved drugs might work better together to treatr filovirus infection. These combinations aim to lower the required dosage of individual drugs and reduce the chances of developing drug-resistant viral strains.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.